Drug · DIN 02229566
TOMUDEX
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 8, 2021; first marketed November 18, 1996.
- Drug Identification Number (DIN)
- 02229566
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Raltitrexed L01BA03
- Class
- Human
- Record last updated
- September 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RALTITREXED | 2 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 8, 2017: NOC 19629New Drug Submission (NDS) · Administrative: Merger - buyout
- May 1, 2008: NOC 9534New Drug Submission (NDS) · Manufacturer name change
- February 15, 2000: NOC 1458New Drug Submission (NDS)
- September 12, 1996: NOC 4628New Drug Submission (NDS)